erdafitinib
Janssen
['erdafitinib']
clinical trials led by our dr. shubham pant and dr. arlene siefker-radtke show promising results when using the targeted therapy drug erdafitinib to treat tumors with fgfr alterations. learn more: #asco23 #endcancer
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789